Stay updated on Durvalumab Consolidation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Consolidation in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page history shows a new revision label (v3.4.2) replacing v3.4.1, a minor site update that does not affect study data or user-facing content; to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed; no substantive content changes to the study record are visible.SummaryDifference0.1%

- Check16 days agoChange DetectedUI updates add a glossary toggle, color-coded diff highlights (green for additions, red for deletions), and a revision label (v3.4.0) with minor capitalization tweaks; the underlying study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check30 days agoChange DetectedNew revision entry v3.3.4 was added to the history, replacing the previous v3.3.3.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision: v3.3.3 was added to the page history, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision entry, Revision: v3.3.2, appears in the study record history, replacing the previous Revision: v3.3.1; layout and data remain otherwise unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Durvalumab Consolidation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Consolidation in NSCLC Clinical Trial page.